The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Celltrion; EUSA Pharma; Gilead Sciences; Immune Design; Janssen-Cilag; Kyowa Hakko Kirin; MSD; Portola Pharmaceuticals; Roche; Sandoz; Sanofi; SERVIER; Verastem
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Celltrion; EUSA Pharma; Gilead Sciences; Immune Design; Janssen-Cilag; Kyowa Hakko Kirin; MSD; Portola Pharmaceuticals; Roche; Sandoz; SERVIER; Verastem
 
Research Funding - Denovo Biopharma; Kymera
The Integration of PD1 blockade with epigenetic therapy is highly active and safe in heavily treated patients with T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL).
 
Enrica Marchi
Consulting or Advisory Role - Mundipharma; Spectrum Pharmaceuticals; Verastem
Research Funding - Celgene (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Mundipharma; Mundipharma; Mundipharma
Other Relationship - Mundipharma
 
Helen Ma
Honoraria - OncLive Clinical Congress Consultants
 
Francesca Montanari
Research Funding - Seagen
 
Ahmed Sawas
Consulting or Advisory Role - Kirin Pharmaceuticals; Pharmacyclics
Speakers' Bureau - Daiichi Sankyo; Gilead Sciences; Seagen
Research Funding - Affimed Therapeutics (Inst); Astellas Pharma (Inst); Trillium Therapeutics (Inst); Viracta Therapeutics (Inst)
 
Jennifer K Lue
No Relationships to Disclose
 
Changchun Deng
Research Funding - Amgen; Bayer; TG Therapeutics
Patents, Royalties, Other Intellectual Property - Columbia University
 
Kareema T Whitfield
No Relationships to Disclose
 
Sandra Klein
No Relationships to Disclose
 
Luigi Scotto
No Relationships to Disclose
 
Salvia Sanjay Jain
No Relationships to Disclose
 
John Lister
Consulting or Advisory Role - Oncology Analytics
 
Nora N Benanni
Consulting or Advisory Role - Adicet Bio (Inst); Purdue Pharma (Inst); Seagen (Inst); Verastem (Inst)
Research Funding - Kite, a Gilead company (Inst)
 
Mark A Francescone
No Relationships to Disclose
 
Wonseog S Kim
No Relationships to Disclose
 
Pier Luigi Zinzani
No Relationships to Disclose
 
Owen A. O'Connor
Honoraria - Millennium; Mundipharma; Novartis; Seagen
Consulting or Advisory Role - Allos Therapeutics; Millennium; Mundipharma; Novartis; Seagen; Spectrum Pharmaceuticals
Research Funding - Acetylon Pharmaceuticals; Celgene; Millennium; Roche; Seagen; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Acetylon Pharmaceuticals; Millennium; Mundipharma; Seagen; Spectrum Pharmaceuticals